Clinical Trial

Intradiscal rhGDF-6 for the Treatment of Lumbar Disc Degeneration

Study acronym: CBT005
Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to find out if a new medicine can help people who have long-lasting back pain caused by damaged spinal discs. The study will also check if the medicine is safe to use. The main questions this study aims to answer are: Is the medicine safe, and what amount works best? Can it reduce long-term back pain? Researchers will test a medicine called CBT005, which contains a healing protein, by injecting it into the spinal discs. They will watch closely to see how people respond to the treatment. Participants will: Receive one study injection into the spinal disc Visit the clinic in person during the first 12 months for checkups Receive phone calls at 24 and 36 months to see how they are doing Still be able to get other pain treatments in the future, including surgery, if needed
Trial Details
NCT Number NCT07668466
Lead Sponsor Cartago Biotech Pty Ltd
Conditions Disc Degenerative Disease, Back Pain
Enrollment 60 participants
Start Date 2026-07-04
Primary Completion 2028-08-31 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-25